Literature DB >> 2459969

Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

H F Dvorak1, J A Nagy, J T Dvorak, A M Dvorak.   

Abstract

The tumor microvasculature is hyperpermeable to plasma proteins, but the specific vessels that leak have not been identified. To investigate this question, the extravasation of circulating tracers of varying size was studied by fluorescence, light, and electron microscopy in animals bearing solid transplantable carcinomas. In all five tumors studied, 70 and 150 kD fluoresceinated (FITC)-dextrans and colloidal carbon leaked extensively from the prominent vascular plexus that was induced around individual tumor nodules and at the tumor-host interface. Leaky vessels were mature veins or venules, lined by a continuous endothelium; most had closed interendothelial cell junctions. Immature interface vessels and tumor-penetrating vessels did not leak these macromolecular tracers significantly. Three kD of FITC-dextran leaked from peripherally situated tumor veins or venules but also extravasated from tumor-penetrating vessels and capillaries supplying normal tissues. These data correlate the functional and anatomic heterogeneity of tumor vessels and provide a rationale for the distribution of circulating molecules such as monoclonal antibodies and tumoricidal drugs in solid tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459969      PMCID: PMC1880651     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Microvascular permeability of normal and neoplastic tissues.

Authors:  L E Gerlowski; R K Jain
Journal:  Microvasc Res       Date:  1986-05       Impact factor: 3.514

2.  Endothelium: a distributed organ of diverse capabilities.

Authors:  A P Fishman
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 3.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

5.  Increase in tumor vascular area due to increased blood flow by angiotensin II in rats.

Authors:  K Hori; M Suzuki; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

6.  Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas.

Authors:  H F Dvorak; V S Harvey; J McDonagh
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

7.  Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.

Authors:  S W O'Connor; W F Bale
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

8.  Vascular resistance characteristics of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and normal tissues as studied in vitro.

Authors:  L Weiss; E Tveit; R Hultborn
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

9.  Differential macromolecular leakage from the vasculature of tumors.

Authors:  L S Heuser; F N Miller
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

10.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more
  142 in total

1.  RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins.

Authors:  K J Bayless; R Salazar; G E Davis
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Immunomodulation of cancer: potential use of selectively replicating agents.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.

Authors:  N S Soukos; M R Hamblin; S Keel; R L Fabian; T F Deutsch; T Hasan
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 4.  Camptothecin delivery methods.

Authors:  A Hatefi; B Amsden
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

Review 5.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

6.  Differing microvasculature in the two major types of gastric carcinoma: a conventional, ultrastructural and ultrastructural immunolocalization study of von Willebrand factor.

Authors:  H Ohtani; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 7.  Review on photoacoustic imaging of the brain using nanoprobes.

Authors:  Depeng Wang; Yun Wu; Jun Xia
Journal:  Neurophotonics       Date:  2016-01-04       Impact factor: 3.593

8.  Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling.

Authors:  Young Hye Song; Seung Hee Shon; Mengrou Shan; Abraham D Stroock; Claudia Fischbach
Journal:  Integr Biol (Camb)       Date:  2016-01-13       Impact factor: 2.192

9.  Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Authors:  P Lin; P Polverini; M Dewhirst; S Shan; P S Rao; K Peters
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

10.  The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association.

Authors:  Xiaoping Zhu; Junmin Peng; Raktima Raychowdhury; Atsushi Nakajima; Wayne I Lencer; Richard S Blumberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.